Colorectal cancer surveillance in inflammatory bowel disease: Practice guidelines and recent developments.
Patients with long-standing inflammatory bowel disease (IBD) involving at least 1/3 of the colon are at increased risk for colorectal cancer (CRC). Advancements in CRC screening and surveillance and improved treatment of IBD has reduced CRC incidence in patients with ulcerative colitis and Crohn's colitis. Most cases of CRC are thought to arise from dysplasia, and recent evidence suggests that the majority of dysplastic lesions in patients with IBD are visible, in part thanks to advancements in high definition colonoscopy and chromoendoscopy. Recent practice guidelines have supported the use of chromoendoscopy with targeted biopsies of visible lesions rather than traditional random biopsies. Endoscopists are encouraged to endoscopically resect visible dysplasia and only recommend surgery when a complete resection is not possible. New technologies such as virtual chromoendoscopy are emerging as potential tools in CRC screening. Patients with IBD at increased risk for developing CRC should undergo surveillance colonoscopy using new approaches and techniques.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Watchful Waiting
- Precancerous Conditions
- Practice Guidelines as Topic
- Mass Screening
- Intestinal Mucosa
- Inflammatory Bowel Diseases
- Humans
- Gastroenterology & Hepatology
- Endoscopic Mucosal Resection
- Early Detection of Cancer
Citation
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Watchful Waiting
- Precancerous Conditions
- Practice Guidelines as Topic
- Mass Screening
- Intestinal Mucosa
- Inflammatory Bowel Diseases
- Humans
- Gastroenterology & Hepatology
- Endoscopic Mucosal Resection
- Early Detection of Cancer